Description

• Atom Pharma is engaged in the manufacturing and development of a wide range of high-quality pharmaceutical drug intermediates, including 4-(2-Chloroethyl)morpholine hydrochloride (CAS No. 3647-69-6). As a leading global manufacturer, Atom Pharma provides this essential intermediate, which plays a key role in the production of active pharmaceutical ingredients (APIs) used in the treatment of head and neck cancer.
  4-(2-Chloroethyl)morpholine hydrochloride is utilized in the synthesis of APIs such as Floredil, Morclofone, Nimorazole, and Pholcodine. These APIs are critical in the development of treatments for various medical conditions, particularly cancer therapies.
  With a dedication to quality, innovation, and global reach, Atom Pharma ensures the consistent availability of this important intermediate for the pharmaceutical industry.